Tag: Avascular Necrosis Market opportunity Analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Avascular Necrosis Market Value Growth And Long-Term Outlook

The avascular necrosis market has demonstrated robust growth in recent years. Looking ahead, it is projected to expand from $0.89 billion in 2025 to $0.97 billion in 2026, at a compound annual growth rate (CAGR) of 9.5%. The historical growth can be attributed to several factors including trauma-related bone injuries, steroid overuse, alcohol consumption, delayed diagnosis, and the overall growth in orthopedic surgery.

The avascular necrosis market size is set to experience substantial growth over the coming years. It is anticipated to reach $1.38 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This expansion during the forecast period is driven by factors such as the increasing adoption of advanced imaging, research in regenerative medicine, an aging demographic, the prevalence of sports injuries, and innovations in orthopedics. Significant trends expected in this period include the rising application of early diagnostic imaging, a greater acceptance of joint-preserving therapies, an increase in minimally invasive surgical procedures, the expansion of physical rehabilitation initiatives, and a dedicated focus on early-stage disease intervention.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Avascular Necrosis Market Growth Factors: What’s Supporting Expansion?

An increasing volume of knee replacements and hip surgeries is anticipated to fuel the expansion of the avascular necrosis market moving forward. These surgical interventions involve replacing compromised joints and alleviating discomfort in advanced instances of avascular necrosis. The rise in these procedures stems from the rising occurrence of osteoarthritis, a condition leading to intense joint pain and mobility challenges, frequently necessitating surgical intervention for relief and enhanced life quality. Avascular necrosis plays a substantial role in the demand for knee and hip replacements, as this condition results in the death of bone tissue due to insufficient blood supply, often leading to joint decay and eventual collapse. For example, in November 2024, data from the American Joint Replacement Registry (AJRR), a US-based registry managed by the American Academy of Orthopaedic Surgeons, revealed that in 2023, over 4 million hip and knee arthroplasty procedures were recorded, signifying an 18% rise from 2022. Consequently, the increasing frequency of knee replacements and hip surgeries is propelling the growth of the avascular necrosis market. The increasing healthcare expenditure is anticipated to drive the expansion of the avascular necrosis market moving forward. Healthcare expenditure represents the total funds allocated to health services, treatments, and medical products within a given population or healthcare system. This spending is on the rise due to the growing prevalence of chronic illnesses, which necessitate ongoing management, frequent hospital visits, and expensive medications. For avascular necrosis, increased healthcare spending is beneficial as it facilitates access to prompt diagnosis, advanced therapeutic options, and surgical procedures that aid in managing the condition and enhancing patient outcomes. For example, in April 2025, the American Medical Association, a US-based professional association and lobbying group for physicians and medical students, reported that health spending in the United States climbed by 7.5% in 2023 to $4.9 trillion, or $14,570 per capita, which was a higher increase than the 4.6% observed in 2022. Consequently, the growth of the avascular necrosis market is being propelled by rising healthcare expenditure.

Avascular Necrosis Market Segment Analysis And Revenue Potential

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Avascular Necrosis Market Key Players Shaping Industry Direction

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

View The Full Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Avascular Necrosis Market Top Region By Revenue And Market Share

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Avascular Necrosis Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for avascular necrosis has experienced notable expansion in recent years. Projections indicate an increase from $0.89 billion in 2025 to $0.97 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.5%. Factors driving growth during the historical period include trauma-induced bone injuries, excessive steroid usage, alcohol intake, delays in diagnosis, and the expansion of orthopedic surgical procedures.

The avascular necrosis market is projected to experience robust expansion over the coming years, reaching a valuation of $1.38 billion by 2030, corresponding to a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by several factors, including the adoption of advanced imaging techniques, ongoing research into regenerative medicine, an aging global population, a high incidence of sports-related injuries, and advancements in orthopedics. Key developments shaping this market encompass the growing utilization of early diagnostic imaging tools, an increasing emphasis on therapies designed to preserve joints, the rise of minimally invasive surgical options, the expansion of physical rehabilitation initiatives, and a heightened focus on managing the condition during its early stages.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Avascular Necrosis Market Growth Momentum: Which Factors Are Influencing Demand?

The anticipated rise in the market for avascular necrosis is being significantly driven by the increasing frequency of knee replacement and hip surgeries. These surgical interventions, designed to replace damaged joints and alleviate pain in advanced cases of avascular necrosis, are becoming more common primarily due to the rising prevalence of osteoarthritis—a condition that leads to severe joint discomfort and impaired mobility, often necessitating surgery for relief and enhanced quality of life. Avascular necrosis itself plays a critical role in driving the demand for these procedures, as it causes bone tissue death from inadequate blood supply, frequently resulting in joint deterioration and collapse. As an example, data from November 2024 released by the American Joint Replacement Registry (AJRR), a registry managed by the American Academy of Orthopaedic Surgeons in the United States, revealed that the number of hip and knee arthroplasty procedures recorded in the registry exceeded 4 million in 2023, reflecting an 18% growth compared to 2022. Consequently, the expansion of the avascular necrosis market is being fueled by this surge in knee replacements and hip surgeries.

Driver: Higher Healthcare Spending Boosts the Avascular Necrosis Market through Better Diagnostics and Treatment Accessibility

The avascular necrosis market is expected to be propelled forward by the increasing level of healthcare spending. This expenditure encompasses the total funds allocated to health services, treatments, and medical products within a given population or healthcare system. The growth in healthcare spending is driven by a higher incidence of chronic diseases, which demand ongoing management, frequent hospital visits, and expensive medications. Such expenditure proves valuable for avascular necrosis by facilitating access to timely diagnoses, advanced therapeutic options, and surgical interventions that help control the condition and enhance patient outcomes. For example, the American Medical Association—a U.S.-based professional organization and advocacy group representing physicians and medical students—reported in April 2025 that health spending in the United States rose by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per person, surpassing the 4.6% increase observed in 2022. Therefore, the upward trend in healthcare expenditure is accelerating the growth of the avascular necrosis market.

Avascular Necrosis Market Categorization By Product Type And Application

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Avascular Necrosis Market Company Landscape And Strategic Competition

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Access The Complete Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Avascular Necrosis Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Avascular Necrosis Market In 2026 And How Much Will It Reach By 2030?

The avascular necrosis market size has experienced significant expansion over recent years. It is anticipated to increase from $0.89 billion in 2025 to $0.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth of this market can be linked to factors like trauma-related bone injuries, excessive steroid use, alcohol intake, late diagnoses, and the rise in orthopedic surgeries.

The avascular necrosis market is anticipated to experience robust expansion over the coming years. Its valuation is set to reach $1.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this growth during the forecast timeframe include the wider uptake of advanced imaging, ongoing research in regenerative medicine, an expanding aging population, the rising incidence of sports injuries, and innovations in orthopedics. Key developments anticipated within the forecast horizon encompass the increasing application of early diagnostic imaging, a greater embrace of joint-preserving treatments, the proliferation of minimally invasive surgical techniques, an expansion of physical rehabilitation initiatives, and an emphasis on interventions for early-stage disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Which Major Factors Are Contributing To The Development Of The Avascular Necrosis Market?

The avascular necrosis market is anticipated to expand due to the increasing volume of knee replacements and hip surgeries. These surgical interventions involve replacing damaged joints and providing pain relief for individuals suffering from severe avascular necrosis. The rising incidence of osteoarthritis, a condition that causes significant joint pain and impaired mobility, often necessitates such surgical procedures for relief and an improved quality of life, thereby contributing to the increase in knee and hip surgeries. Moreover, avascular necrosis itself, characterized by the death of bone tissue due to reduced blood supply, is a major factor in the demand for knee replacements and hip surgeries, frequently resulting in joint deterioration and collapse. For instance, in November 2024, the American Joint Replacement Registry (AJRR), a US-based registry managed by the American Academy of Orthopaedic Surgeons, reported that in 2023, the number of hip and knee arthroplasty procedures recorded in its registry exceeded 4 million, marking an 18% increase compared to 2022. Consequently, the growing number of knee replacements and hip surgeries is driving the growth of the avascular necrosis market.

How Is The Avascular Necrosis Market Distributed Across Key Segments?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Who Are The Major Companies Operating In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Access The Complete Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Has The Strongest Presence In The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Avascular Necrosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Avascular Necrosis Market Projected To Reach By 2030?

The avascular necrosis market size has experienced robust expansion in recent years. It is projected to increase from $0.89 billion in 2025 to $0.97 billion in 2026, with a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to elements such as trauma-related bone injuries, steroid overuse, alcohol consumption, delayed diagnosis, and the expansion of orthopedic surgery.

The avascular necrosis market is anticipated to experience robust expansion over the coming years. This market is projected to reach $1.38 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.2%. The expansion during the forecast period is fueled by factors such as the increasing acceptance of advanced imaging techniques, ongoing research in regenerative medicine, an expanding aging population, the widespread occurrence of sports injuries, and continuous innovation in orthopedics. Key developments expected during this period include a heightened emphasis on early diagnostic imaging, greater uptake of therapies aimed at preserving joints, an increase in minimally invasive surgical procedures, the broadening of physical rehabilitation initiatives, and a strategic focus on intervening in the early stages of the disease.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Major Factors Are Driving The Avascular Necrosis Market Forward?

The avascular necrosis market is anticipated to expand due to the increasing frequency of knee replacements and hip surgeries. These procedures involve surgical interventions to substitute impaired joints and alleviate discomfort in advanced stages of avascular necrosis. The rise in these surgeries stems from the rising occurrence of osteoarthritis, a condition leading to intense joint pain and restricted movement, frequently necessitating surgery for relief and better life quality. Avascular necrosis is a key factor driving the demand for knee and hip replacements, as the condition causes bone tissue to die due to insufficient blood flow, often resulting in joint damage and failure. For example, the American Joint Replacement Registry (AJRR), a US-based registry managed by the American Academy of Orthopaedic Surgeons, reported in November 2024 that hip and knee arthroplasty procedures recorded in 2023 exceeded 4 million, an 18% increase over 2022. Consequently, the increasing volume of knee and hip replacement surgeries is fueling the expansion of the avascular necrosis market.

How Is The Avascular Necrosis Market Organized By Segment Classification?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Who Are The Industry Participants Involved In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Get The Full Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Is The Leading Market For The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Avascular Necrosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Avascular Necrosis Market From 2026 To 2030?

The avascular necrosis market has shown robust expansion in recent years. It is anticipated to increase from $0.89 billion in 2025 to $0.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. The expansion observed in the past can be linked to factors like trauma-related bone injuries, excessive steroid consumption, alcohol intake, late diagnoses, and the rise in orthopedic procedures.

The avascular necrosis market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $1.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth is primarily driven by factors such as the increasing adoption of advanced imaging techniques, ongoing research in regenerative medicine, a growing aging population, the rising prevalence of sports injuries, and continuous innovation in orthopedics. Key trends expected during this period encompass the escalating utilization of early diagnostic imaging, a wider embrace of joint-preserving therapeutic approaches, an increase in minimally invasive surgical interventions, the broadening of physical rehabilitation initiatives, and a stronger emphasis on intervening in the early stages of the disease.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Major Drivers Are Influencing Demand In The Avascular Necrosis Market?

The avascular necrosis market is anticipated to expand due to the increasing volume of knee and hip replacement procedures. These surgical interventions involve replacing compromised joints to alleviate pain, particularly in advanced instances of avascular necrosis. The rise in these surgeries stems from the widespread increase in osteoarthritis, a condition causing intense joint pain and mobility challenges, frequently necessitating surgery for relief and better quality of life. Avascular necrosis itself is a major factor driving the demand for knee and hip replacements, as it leads to bone tissue death from insufficient blood supply, resulting in joint breakdown and collapse. For example, data from November 2024, reported by the American Joint Replacement Registry (AJRR) – a US-based registry managed by the American Academy of Orthopaedic Surgeons – indicated that hip and knee arthroplasty procedures recorded in 2023 exceeded 4 million, representing an 18% rise from 2022. Consequently, the increasing frequency of knee replacements and hip surgeries is fueling the expansion of the avascular necrosis market.

Which Segments Are Included In The Analysis Of The Avascular Necrosis Market?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Which Key Industry Participants Are Active In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Read the full avascular necrosis market report here:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Avascular Necrosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the avascular necrosis market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Avascular Necrosis Market?

The avascular necrosis market has experienced robust expansion in recent years. This market is projected to expand from $0.89 billion in 2025 to $0.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. Historically, this expansion has been driven by factors such as trauma-related bone injuries, excessive steroid use, alcohol consumption, delayed diagnosis, and the rise in orthopedic surgeries.

The avascular necrosis market is projected to experience substantial growth over the upcoming years, reaching a valuation of $1.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This expansion during the forecast period is fueled by factors such as the increasing adoption of advanced imaging techniques, ongoing research in regenerative medicine, a growing aging population, the prevalence of sports injuries, and continuous innovation in orthopedics. Key trends anticipated within this period involve the increasing utilization of early diagnostic imaging, a rise in the adoption of joint-preserving treatments, the proliferation of minimally invasive surgical procedures, the broadening of physical rehabilitation initiatives, and an emphasis on intervening at the early stages of the disease.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Drivers Are Supporting Technological Adoption In The Avascular Necrosis Market?

The expansion of knee replacement and hip surgery procedures is anticipated to fuel the expansion of the avascular necrosis market. These surgical interventions are performed to substitute compromised joints and alleviate discomfort in advanced cases of avascular necrosis. The volume of these surgeries is climbing due to the increasing incidence of osteoarthritis, a condition that results in intense joint pain and mobility challenges, often necessitating surgery for relief and improved quality of life. Avascular necrosis plays a substantial role in the demand for knee replacements and hip surgeries, as it involves the demise of bone tissue due to inadequate blood supply, frequently resulting in joint decay and collapse. For instance, in November 2024, the American Joint Replacement Registry (AJRR), a US-based registry run by the American Academy of Orthopaedic Surgeons, indicated that in 2023, the number of hip and knee arthroplasty procedures captured in the registry exceeded 4 million, representing an 18% increase compared to 2022. Consequently, the growing frequency of knee replacements and hip surgeries is propelling the avascular necrosis market forward.

Avascular Necrosis Market Driver: Rising Healthcare Expenditure Fuelling The Growth Of The Market Due To Improving Diagnostics And Treatment Access

The escalating healthcare expenditure is anticipated to drive the expansion of the avascular necrosis market. Healthcare expenditure encompasses the total funds allocated to health services, treatments, and medical supplies within a given population or healthcare framework. This expenditure is on the rise primarily due to the increasing incidence of chronic diseases, which demand continuous management, frequent hospital visits, and costly pharmaceutical interventions. For avascular necrosis, increased healthcare spending is beneficial as it facilitates access to prompt diagnosis, sophisticated treatments, and surgical options, all of which contribute to managing the condition and enhancing patient recovery. For instance, in April 2025, as reported by the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, health spending in the United States climbed by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, surpassing the 4.6% increase observed in 2022. Consequently, the upward trend in healthcare expenditure is stimulating the growth of the avascular necrosis market.

What Segment Types Are Examined In The Avascular Necrosis Market?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Who Are The Major Companies Operating In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Avascular Necrosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Avascular Necrosis Industry Compare Between 2025 And 2029?

The avascular necrosis market has seen robust expansion in recent years. It is forecast to grow from $0.81 billion in 2024 to $0.89 billion in 2025, at a compound annual growth rate (CAGR) of 9.7%. The market’s historical growth can be ascribed to an increase in the aging population, rising alcohol consumption, the development of sports medicine, the expansion of medical tourism, and progress in precision medicine.

The avascular necrosis market is projected to experience robust expansion in the coming years. It is anticipated to reach $1.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. This anticipated growth throughout the forecast period stems from factors such as the increasing occurrence of corticosteroid-associated osteonecrosis, the rising volume of knee replacement and hip surgical procedures, an escalating number of drug authorizations, a greater frequency of road accidents, and a surge in bone injury incidents. Key trends projected for this period encompass technological innovations, sophisticated imaging techniques, AI-driven diagnostic instruments, 3D-printed surgical solutions, regenerative orthobiological treatments, and cellular therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Which Industry Drivers Are Expected To Accelerate The Avascular Necrosis Market From 2025 To 2029?

The avascular necrosis market is anticipated to expand due to an increasing volume of knee replacements and hip surgeries. These surgical interventions are procedures conducted to substitute compromised joints and alleviate discomfort in advanced stages of avascular necrosis. The rise in such operations is attributable to the rising occurrence of osteoarthritis, a condition that leads to intense joint pain and mobility problems, frequently necessitating surgery for relief and a better quality of life. Avascular necrosis itself is a major factor driving the demand for knee and hip replacements, as it involves the death of bone tissue resulting from insufficient blood supply, often culminating in joint degradation and collapse. For example, Curvo Labs, Inc., a US-based healthcare technology company, reported in September 2023 that knee replacement procedures in the U.S. saw an increase from 1,235,835 in 2021 to 1,299,084 in 2022. Consequently, the increasing frequency of knee replacements and hip surgeries is a key factor propelling the avascular necrosis market. Future expansion of the avascular necrosis market is anticipated to be fueled by increasing healthcare expenditure. This refers to the cumulative spending on health services, therapeutic interventions, and medical commodities within a given populace or healthcare infrastructure. Healthcare spending is on the rise, primarily driven by the escalating incidence of chronic illnesses that demand ongoing management, frequent hospitalizations, and expensive medications. For avascular necrosis, greater healthcare expenditure facilitates timely diagnostic services, sophisticated treatment options, and surgical interventions, all of which are crucial for managing the condition and enhancing patient prognoses. For instance, the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, stated in April 2025 that health spending in the United States surged by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, which represents an acceleration from the 4.6% increase observed in 2022. Thus, the growth of the avascular necrosis market is being propelled by rising healthcare expenditure.

What Are The Major Segment Types Covered In The Avascular Necrosis Market?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegment:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Which Key Trends Are Expected To Influence The Avascular Necrosis Market In The Coming Years?

Major companies operating within the avascular necrosis market are actively seeking and obtaining regulatory approvals to broaden their product portfolios, enhance existing treatment options, and strengthen their position in the market. Regulatory approvals signify official permissions provided by health authorities, enabling a medical product or treatment to be marketed and used after successfully meeting all necessary safety and efficacy benchmarks. For example, in May 2022, Regrow Biosciences, an India-based biotechnology company, secured approval from the United States Food and Drug Administration to initiate Phase II clinical trials in the US for OSSGROW. OSSGROW is an orphan drug designated for addressing osteonecrosis, which is another term for avascular necrosis. This pioneering, personalized bone cell therapy was developed by Regrow Biosciences for the curative treatment of avascular necrosis (AVN) in its early to moderate stages (up to Stage III). The therapy functions by extracting mesenchymal stem cells from the patient’s bone marrow, which are then cultivated in a specialized laboratory to develop into bone-forming cells known as osteoblasts. OSSGROW is recognized as a natural, safe, and potentially permanent solution, aiming to provide an alternative to traditional treatments and joint replacement surgeries that currently only manage symptoms.

Which Global Market Leaders Are Shaping The Future Of The Avascular Necrosis Sector?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc., Ginger Healthcare Private Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

How Does The Avascular Necrosis Market Perform Across Key Geographic Regions?

North America was the largest region in the avascular necrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2025, By The Business Research Company

Peripheral Artery Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Avascular Necrosis Industry?

The market for avascular necrosis has seen robust growth in the past few years. The market will escalate from $0.81 billion in 2024 to $0.89 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. The augmentation in historical periods can be credited to factors such as a growing elderly population, upsurge in alcohol intake, advancements in sports medicine, burgeoning medical tourism, and expansion in precision medicine.

In the coming years, it is predicted that the market size for avascular necrosis will experience considerable growth, and it is anticipated to expand to a value of $1.27 billion in 2029. The rate of growth is expected to be a compound annual growth rate (CAGR) of 9.3%. This trend of growth during the forecast period is due to a surge in the occurrence of corticosteroid-related osteonecrosis, an increase in knee and hip replacement surgeries, more approvals of drugs, a rise in the number of road accidents, and a growing number of bone injury cases. Major trends that will appear during the forecast period include technological advancements such as high-tech imaging technologies, diagnostic tools based on artificial intelligence, surgical implants made through 3D printing, regenerative orthobiologics, and cell therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Forces Are Driving The Growth Of The Avascular Necrosis Industry?

The escalation in knee replacement and hip surgeries brought on by avascular necrosis is projected to magnify the expansion of the avascular necrosis market in the future. These corrective procedures involve the replacement of impaired joints inflicted by severe instances of avascular necrosis in order to alleviate pain. Aging and the increasing rates of osteoarthritis, which often lead to significant pain in the joints and movement issues, necessitate surgical aid for respite and enhancement of life quality. Knee replacement and hip surgery demands surge because of avascular necrosis, the medical condition that triggers the death of bone tissues due to deficiency in blood supply, often leading to the malfunction and disintegration of joints. As per Curvo Labs, Inc., an American healthcare technology firm, in September 2023, the count of knee replacement operations in the U.S. rose from 1,235,835 in 2021 to 1,299,084 in 2022. Therefore, the surging demand for knee replacements and hip surgeries bolsters the growth of the avascular necrosis market. The increasing costs dedicated to healthcare is anticipated to facilitate the growth of the avascular necrosis market in the future. Healthcare expenditure encompasses the consolidated sum invested in health services, treatments, and medicinal goods within a particular demographic or healthcare system. The spending on healthcare is escalating due to the rising occurrence of chronic illnesses which necessitate long-term supervision, recurrent hospital visits, and expensive prescriptions. This expenditure proves beneficial for avascular necrosis by offering access to prompt diagnosis, state-of-the-art treatments, and surgeries that aid in managing the ailment and enhancing patient survival. The American Medical Association, an American professional and lobbying organization comprised of physicians and medical students, reported in April 2025 that health expenditure in the United States jumped by 7.5% in 2023, reaching a total of $4.9 trillion, or $14,570 per person which is greater than the 4.6% growth rate in 2022. Hence, the rising healthcare expenditure is fuelling the growth of the avascular necrosis market.

What Is The Overview Of Market Segmentation In The Avascular Necrosis Industry?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegment:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

What Future Market Trends Are Projected For The Avascular Necrosis Industry?

In the avascular necrosis market, dominant corporations are striving for regulatory authorizations to broaden their product range, improve treatment alternatives and solidify their market influence. Regulatory authorizations are official authorizations bestowed by health authorities, permitting a medical product or treatment to be marketed and implemented upon satisfying safety and efficacy requirements. For example, in May 2022, an approval was granted by the United States Food and Drug Administration to Regrow Biosciences, a biotechnology organization based in India. This allowed them to operate Phase II clinical examinations in the US for their orphan drug OSSGROW, used for the treatment of osteonecrosis, also known as avascular necrosis. OSSGROW, a cutting-edge personalized bone cell therapy system, was developed for the curative treatment of early to moderate (up to Stage III) avascular necrosis (AVN) by Regrow Biosciences. The therapy utilizes the patient’s bone marrow, wherein mesenchymal stem cells are cultivated and morphed into osteoblasts, cells that form bones, through a specialized laboratory process. OSSGROW is considered a natural, secure, and potentially permanent solution, intending to substitute traditional treatments and joint replacement surgeries that only manage symptoms.

Who Are The Primary Players Operating Across The Global Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc., Ginger Healthcare Private Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Offers The Most Growth Potential For The Avascular Necrosis Market Through 2029?

North America was the largest region in the avascular necrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Avascular Necrosis Market from 2024 to 2025?

Over the past few years, the size of the avascular necrosis market has seen significant expansion. The projections predict that it will rise from $0.81 billion in 2024 to $0.89 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. This surge during the earlier period is the result of factors such as the increasing aging population, rising alcohol consumption, advancements in sports medicine, expansion in medical tourism, and the growth of precision medicine.

What Is the Projected Market Size of the Avascular Necrosis Market?

The market size for avascular necrosis is projected to experience significant expansion in the coming years, escalating to $1.27 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in this period is linked to factors such as increasing cases of osteonecrosis related to corticosteroid use, a rise in knee and hip replacement procedures, an uptick in drug approvals, an increase in road accidents, and a surge in bone injury cases. Forecasted trends driving this market include technological innovation, cutting-edge imaging technologies, diagnostic tools based on artificial intelligence, surgically implanted 3D prints, regenerative orthobiologic therapies, and cell therapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

Who are the Major Competitors in the Avascular Necrosis Market Outlook?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc., Ginger Healthcare Private Limited

What Is Fueling Growth in the Avascular Necrosis Market?

The surging frequency of hip and knee replacement surgeries is projected to drive the growth of the avascular necrosis market in the future. These surgical procedures, which entail the replacement of damaged joints, are employed to alleviate severe pain resulting from avascular necrosis. The escalating rates of such replacements stem from an increased incidence of osteoarthritis, a condition that leads to significant joint pain and mobility problems, often necessitating surgical intervention to mitigate pain and enhance life’s quality. Avascular necrosis, a condition leading to bone tissue death due to inadequate blood supply and eventually joint breakdown, heavily contributes to the rising need for knee and hip replacements. For instance, Curvo Labs, Inc., a U.S. healthcare technology firm, reported in September 2023 that the number of knee replacements in the U.S. rose from 1,235,835 in 2021 to 1,299,084 in 2022. Hence, the rising number of knee and hip replacement surgeries is fueling the avascular necrosis market’s growth. The growth of the avascular necrosis market is also likely to be stimulated by the escalating healthcare expenditure, as it boosts access to improved diagnostic and treatment options. The total outlay on health services, medical products, and treatments across a healthcare system or population constitutes healthcare expenditure. This expenditure is increasing due to the growing presence of chronic diseases that necessitate long-term management, frequent hospital trips, and expensive medications. Such expenditure can enhance avascular necrosis management by ensuring access to prompt diagnosis, advanced therapies, and surgical operations that can better manage the situation and improve patient results. For instance, in April 2025, the American Medical Association pointed out that health spending in the U.S. rose by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, a significant increase from the 4.6% rise in 2022. Consequently, the growing healthcare expenditure is propelling the growth of the avascular necrosis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24476&type=smp

Which Avascular Necrosis Market Segments Are Growing the Fastest?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegment:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Which Industry Trends Are Shaping the Future of the Avascular Necrosis Market?

Leading businesses in the avascular necrosis market are securing regulatory approvals to broaden their offerings, improve therapeutic possibilities, and consolidate their market position. Regulatory approvals define as official consents provided by health regulators permitting a medical product or procedure to be marketed and utilized after achieving safety and efficacy criteria. For example, Regrow Biosciences, a biotech company from India obtained approval from the US Food and Drug Administration in May 2022 to carry out Phase II clinical studies in the US for its drug OSSGROW, used in the treatment of osteonecrosis or avascular necrosis. OSSGROW, an innovative, tailor-made bone cell therapy, was designed by Regrow Biosciences to cure the early to moderate phases (up to stage III) of avascular necrosis also termed as osteonecrosis. The procedure involves extracting mesenchymal stem cells from the patient’s bone marrow and culturing them in a specialized lab to become osteoblasts or bone-forming cells. OSSGROW is seen as a natural, safe, and potentially lasting solution, intending to supersede conventional treatments and joint replacement operations that only alleviate symptoms.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Countries Are Leading the Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24476

This Report Delivers Insight On:

1. How big is the avascular necrosis market, and how is it changing globally?

2. Who are the major companies in the avascular necrosis market, and how are they performing?

3. What are the key opportunities and risks in the avascular necrosis market right now?

4. Which products or customer segments are growing the most in the avascular necrosis market?

5. What factors are helping or slowing down the growth of the avascular necrosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model